

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.67011152 |
| 2 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.55117411 |
| 3 | positive regulation of B cell differentiation (GO:0045579) | 3.90559390 |
| 4 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.67273019 |
| 5 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.67273019 |
| 6 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.67273019 |
| 7 | modulation by symbiont of host immune response (GO:0052553) | 3.67273019 |
| 8 | positive regulation by symbiont of host defense response (GO:0052509) | 3.67273019 |
| 9 | modulation by symbiont of host defense response (GO:0052031) | 3.67273019 |
| 10 | negative regulation of phagocytosis (GO:0050765) | 3.61331937 |
| 11 | neutrophil activation involved in immune response (GO:0002283) | 3.49962742 |
| 12 | regulation of B cell differentiation (GO:0045577) | 3.47470408 |
| 13 | * definitive hemopoiesis (GO:0060216) | 3.45631070 |
| 14 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.38311613 |
| 15 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.29665221 |
| 16 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.27391351 |
| 17 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.27391351 |
| 18 | response to muramyl dipeptide (GO:0032495) | 3.26749604 |
| 19 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.22872420 |
| 20 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.19189605 |
| 21 | immunoglobulin mediated immune response (GO:0016064) | 3.19039143 |
| 22 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.17845137 |
| 23 | hypotonic response (GO:0006971) | 3.17231664 |
| 24 | regulation of gamma-delta T cell activation (GO:0046643) | 3.16937674 |
| 25 | regulation of vitamin D biosynthetic process (GO:0060556) | 3.14574730 |
| 26 | response to protozoan (GO:0001562) | 3.12089634 |
| 27 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.08150786 |
| 28 | pinocytosis (GO:0006907) | 3.03466606 |
| 29 | leukocyte aggregation (GO:0070486) | 3.01298581 |
| 30 | positive regulation of macrophage differentiation (GO:0045651) | 2.99488037 |
| 31 | megakaryocyte development (GO:0035855) | 2.95479626 |
| 32 | cellular response to exogenous dsRNA (GO:0071360) | 2.95221059 |
| 33 | B cell receptor signaling pathway (GO:0050853) | 2.94957873 |
| 34 | response to peptidoglycan (GO:0032494) | 2.94863208 |
| 35 | embryonic process involved in female pregnancy (GO:0060136) | 2.93580900 |
| 36 | hepatocyte apoptotic process (GO:0097284) | 2.92547362 |
| 37 | negative regulation of interleukin-8 production (GO:0032717) | 2.90759303 |
| 38 | ribosomal small subunit assembly (GO:0000028) | 2.90139983 |
| 39 | germinal center formation (GO:0002467) | 2.90059102 |
| 40 | neutrophil activation (GO:0042119) | 2.86894902 |
| 41 | mannose metabolic process (GO:0006013) | 2.85839931 |
| 42 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.83404897 |
| 43 | myeloid dendritic cell activation (GO:0001773) | 2.82694013 |
| 44 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.82472680 |
| 45 | tolerance induction (GO:0002507) | 2.81482424 |
| 46 | mast cell activation (GO:0045576) | 2.79928086 |
| 47 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.79200962 |
| 48 | macrophage activation involved in immune response (GO:0002281) | 2.78637149 |
| 49 | defense response to protozoan (GO:0042832) | 2.76561966 |
| 50 | T cell homeostasis (GO:0043029) | 2.76380457 |
| 51 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.75044633 |
| 52 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.72998005 |
| 53 | angiogenesis involved in wound healing (GO:0060055) | 2.72683735 |
| 54 | B cell homeostasis (GO:0001782) | 2.72149515 |
| 55 | myeloid cell activation involved in immune response (GO:0002275) | 2.68568130 |
| 56 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.66413702 |
| 57 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 2.65206489 |
| 58 | tyrosine phosphorylation of STAT protein (GO:0007260) | 2.63822710 |
| 59 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.62894987 |
| 60 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.62894987 |
| 61 | neutrophil mediated immunity (GO:0002446) | 2.62510397 |
| 62 | positive regulation of vasculogenesis (GO:2001214) | 2.61883774 |
| 63 | granulocyte activation (GO:0036230) | 2.61808497 |
| 64 | regulation of platelet aggregation (GO:0090330) | 2.60195695 |
| 65 | lymphocyte homeostasis (GO:0002260) | 2.60106716 |
| 66 | regulation of mast cell degranulation (GO:0043304) | 2.60071343 |
| 67 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.59485837 |
| 68 | regulation of macrophage cytokine production (GO:0010935) | 2.59046731 |
| 69 | positive regulation of interferon-alpha production (GO:0032727) | 2.58943873 |
| 70 | negative thymic T cell selection (GO:0045060) | 2.58116009 |
| 71 | negative regulation of interleukin-12 production (GO:0032695) | 2.58060037 |
| 72 | regulation of integrin activation (GO:0033623) | 2.57531024 |
| 73 | positive thymic T cell selection (GO:0045059) | 2.56468097 |
| 74 | regulation of leukocyte degranulation (GO:0043300) | 2.56015029 |
| 75 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 2.55798288 |
| 76 | negative regulation of interleukin-6 production (GO:0032715) | 2.53485593 |
| 77 | positive regulation of tolerance induction (GO:0002645) | 2.53082792 |
| 78 | regulation of necroptotic process (GO:0060544) | 2.53080877 |
| 79 | regulation of interferon-alpha production (GO:0032647) | 2.52999196 |
| 80 | response to laminar fluid shear stress (GO:0034616) | 2.52485071 |
| 81 | detection of molecule of bacterial origin (GO:0032490) | 2.51958321 |
| 82 | respiratory burst (GO:0045730) | 2.51951021 |
| 83 | regulation of tolerance induction (GO:0002643) | 2.51305548 |
| 84 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.50920443 |
| 85 | mature B cell differentiation involved in immune response (GO:0002313) | 2.50681466 |
| 86 | regulation of erythrocyte differentiation (GO:0045646) | 2.50577629 |
| 87 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.50398677 |
| 88 | response to host (GO:0075136) | 2.50398677 |
| 89 | response to host defenses (GO:0052200) | 2.50398677 |
| 90 | regulation of mast cell activation (GO:0033003) | 2.50236092 |
| 91 | negative regulation of cell killing (GO:0031342) | 2.48348812 |
| 92 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.48348812 |
| 93 | response to host immune response (GO:0052572) | 2.47306667 |
| 94 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.47306667 |
| 95 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.47041051 |
| 96 | B cell mediated immunity (GO:0019724) | 2.46907547 |
| 97 | mature B cell differentiation (GO:0002335) | 2.46827575 |
| 98 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.46767108 |
| 99 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.46425447 |
| 100 | interferon-gamma production (GO:0032609) | 2.46266971 |
| 101 | mucosal-associated lymphoid tissue development (GO:0048537) | 2.45202691 |
| 102 | Peyers patch development (GO:0048541) | 2.45202691 |
| 103 | positive regulation of natural killer cell differentiation (GO:0032825) | 2.44975874 |
| 104 | negative T cell selection (GO:0043383) | 2.44595172 |
| 105 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.44183574 |
| 106 | positive regulation of B cell activation (GO:0050871) | 2.44158774 |
| 107 | negative regulation of T cell mediated immunity (GO:0002710) | 2.44027871 |
| 108 | thrombin receptor signaling pathway (GO:0070493) | 2.43423429 |
| 109 | regulation of vitamin metabolic process (GO:0030656) | 2.42314230 |
| 110 | response to type I interferon (GO:0034340) | 2.42298865 |
| 111 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 2.41194622 |
| 112 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.40936112 |
| 113 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.40331711 |
| 114 | membrane raft organization (GO:0031579) | 2.40264229 |
| 115 | response to interferon-alpha (GO:0035455) | 2.40110073 |
| 116 | establishment of endothelial barrier (GO:0061028) | 2.39733620 |
| 117 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.39589799 |
| 118 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.39225191 |
| 119 | negative regulation of B cell proliferation (GO:0030889) | 2.39200792 |
| 120 | cellular extravasation (GO:0045123) | 2.39064994 |
| 121 | positive regulation of mast cell degranulation (GO:0043306) | 2.38809818 |
| 122 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.38809818 |
| 123 | lymph node development (GO:0048535) | 2.38411790 |
| 124 | myeloid dendritic cell differentiation (GO:0043011) | 2.38375347 |
| 125 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 2.37543302 |
| 126 | positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516) | 2.37455341 |
| 127 | cellular response to ethanol (GO:0071361) | 2.37144951 |
| 128 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 2.36844334 |
| 129 | type I interferon signaling pathway (GO:0060337) | 2.36597284 |
| 130 | cellular response to type I interferon (GO:0071357) | 2.36597284 |
| 131 | NIK/NF-kappaB signaling (GO:0038061) | 2.36520727 |
| 132 | myeloid leukocyte activation (GO:0002274) | 2.35825426 |
| 133 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.35721008 |
| 134 | positive regulation of T-helper cell differentiation (GO:0045624) | 2.35088293 |
| 135 | positive regulation of natural killer cell activation (GO:0032816) | 2.34518375 |
| 136 | leukocyte homeostasis (GO:0001776) | 2.34398572 |
| 137 | positive regulation of isotype switching (GO:0045830) | 2.33790327 |
| 138 | skin morphogenesis (GO:0043589) | 2.33362249 |
| 139 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.32860989 |
| 140 | positive regulation of protein import into nucleus, translocation (GO:0033160) | 2.32621670 |
| 141 | positive regulation of mast cell activation (GO:0033005) | 2.32118418 |
| 142 | germ cell migration (GO:0008354) | 2.31786954 |
| 143 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.31707568 |
| 144 | positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557) | 2.31216032 |
| 145 | positive regulation of alpha-beta T cell differentiation (GO:0046638) | 2.31200994 |
| 146 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.30238776 |
| 147 | positive regulation of tumor necrosis factor production (GO:0032760) | 2.29744359 |
| 148 | regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370) | 2.27287417 |
| 149 | nerve growth factor signaling pathway (GO:0038180) | 2.27269434 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 4.88479664 |
| 2 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 4.61595947 |
| 3 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.52534665 |
| 4 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 4.43456768 |
| 5 | * STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.98969978 |
| 6 | * IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.87692849 |
| 7 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.44186679 |
| 8 | * SCL_19346495_ChIP-Seq_HPC-7_Human | 3.42772348 |
| 9 | * MYB_21317192_ChIP-Seq_ERMYB_Mouse | 3.09495455 |
| 10 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.07382357 |
| 11 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.99340207 |
| 12 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.76369496 |
| 13 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.75033792 |
| 14 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.74893816 |
| 15 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.72653673 |
| 16 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.71089964 |
| 17 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.44754853 |
| 18 | MYC_22102868_ChIP-Seq_BL_Human | 2.41853831 |
| 19 | * VDR_21846776_ChIP-Seq_THP-1_Human | 2.34606595 |
| 20 | * MYB_26560356_Chip-Seq_TH2_Human | 2.30276070 |
| 21 | * RUNX_20019798_ChIP-Seq_JUKART_Human | 2.23615312 |
| 22 | * VDR_24763502_ChIP-Seq_THP-1_Human | 2.19673181 |
| 23 | * STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.16710670 |
| 24 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.14861961 |
| 25 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.14854210 |
| 26 | * SPI1_23547873_ChIP-Seq_NB4_Human | 2.14723201 |
| 27 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.10773437 |
| 28 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.10190632 |
| 29 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.09054372 |
| 30 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 2.05499625 |
| 31 | * MAF_26560356_Chip-Seq_TH1_Human | 2.05109827 |
| 32 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.05068037 |
| 33 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.00221430 |
| 34 | MYB_26560356_Chip-Seq_TH1_Human | 1.99080593 |
| 35 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.98499396 |
| 36 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.94984616 |
| 37 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 1.92731600 |
| 38 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.89451407 |
| 39 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.89162847 |
| 40 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.88884499 |
| 41 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.84084545 |
| 42 | UTX_26944678_Chip-Seq_JUKART_Human | 1.69179770 |
| 43 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.66162502 |
| 44 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.64137871 |
| 45 | GATA1_22025678_ChIP-Seq_K562_Human | 1.60535608 |
| 46 | * SPI1_23127762_ChIP-Seq_K562_Human | 1.59035704 |
| 47 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.57262095 |
| 48 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.56602893 |
| 49 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.55905445 |
| 50 | * GATA1_19941826_ChIP-Seq_K562_Human | 1.50527627 |
| 51 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.49679188 |
| 52 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.49129473 |
| 53 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.41047042 |
| 54 | * E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.37005455 |
| 55 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.36568583 |
| 56 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.34152852 |
| 57 | * GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.33489949 |
| 58 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.31062490 |
| 59 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.30703112 |
| 60 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.30452993 |
| 61 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.30087006 |
| 62 | * BRD4_25478319_ChIP-Seq_HGPS_Human | 1.29830051 |
| 63 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.27320456 |
| 64 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.26911174 |
| 65 | * GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.25628043 |
| 66 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.24883863 |
| 67 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.24716577 |
| 68 | * GATA2_19941826_ChIP-Seq_K562_Human | 1.21986856 |
| 69 | * KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.21789912 |
| 70 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.20705298 |
| 71 | * SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.19515806 |
| 72 | * SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.19515806 |
| 73 | * GATA3_27048872_Chip-Seq_THYMUS_Human | 1.19376305 |
| 74 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.18847543 |
| 75 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.17987025 |
| 76 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.17792653 |
| 77 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.17588158 |
| 78 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.16236045 |
| 79 | * CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.12925025 |
| 80 | * JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.10886968 |
| 81 | MAF_26560356_Chip-Seq_TH2_Human | 1.10485232 |
| 82 | * JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.10420738 |
| 83 | * KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.09222399 |
| 84 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.09040298 |
| 85 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.08990158 |
| 86 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.08456921 |
| 87 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.07852324 |
| 88 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.07764936 |
| 89 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.04740120 |
| 90 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.03242315 |
| 91 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.01764067 |
| 92 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.01528931 |
| 93 | * KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.01453802 |
| 94 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 1.01147460 |
| 95 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.00180526 |
| 96 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.00106240 |
| 97 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.00010859 |
| 98 | * PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.00009989 |
| 99 | ELK1_19687146_ChIP-ChIP_HELA_Human | 0.99625220 |
| 100 | * SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.98927780 |
| 101 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.98280549 |
| 102 | * ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.97591044 |
| 103 | * CJUN_26792858_Chip-Seq_BT549_Human | 0.96785126 |
| 104 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.96238874 |
| 105 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.95270563 |
| 106 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.94679284 |
| 107 | GATA3_26560356_Chip-Seq_TH2_Human | 0.93433522 |
| 108 | * NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.92970275 |
| 109 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.92435625 |
| 110 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.92157583 |
| 111 | * RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.92123359 |
| 112 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.91717970 |
| 113 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 0.91086754 |
| 114 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.90548160 |
| 115 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.89707328 |
| 116 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.89438721 |
| 117 | * KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.88186969 |
| 118 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.85055149 |
| 119 | * CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.84086042 |
| 120 | * NCOR1_26117541_ChIP-Seq_K562_Human | 0.83564554 |
| 121 | CIITA_25753668_ChIP-Seq_RAJI_Human | 0.81673355 |
| 122 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.79516643 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 3.15959229 |
| 2 | * MP0002396_abnormal_hematopoietic_system | 2.67733300 |
| 3 | MP0003436_decreased_susceptibility_to | 2.61952166 |
| 4 | MP0009278_abnormal_bone_marrow | 2.41411973 |
| 5 | MP0001545_abnormal_hematopoietic_system | 2.40497206 |
| 6 | MP0005397_hematopoietic_system_phenotyp | 2.40497206 |
| 7 | MP0003300_gastrointestinal_ulcer | 2.31482130 |
| 8 | * MP0004808_abnormal_hematopoietic_stem | 2.30741387 |
| 9 | MP0001800_abnormal_humoral_immune | 2.29280628 |
| 10 | MP0002419_abnormal_innate_immunity | 2.28962303 |
| 11 | MP0002452_abnormal_antigen_presenting | 2.25759477 |
| 12 | MP0002148_abnormal_hypersensitivity_rea | 2.24347720 |
| 13 | MP0005000_abnormal_immune_tolerance | 2.24260312 |
| 14 | MP0000685_abnormal_immune_system | 2.24213190 |
| 15 | MP0005671_abnormal_response_to | 2.22078688 |
| 16 | MP0005387_immune_system_phenotype | 2.21929758 |
| 17 | MP0001790_abnormal_immune_system | 2.21929758 |
| 18 | MP0005464_abnormal_platelet_physiology | 2.20700144 |
| 19 | MP0009785_altered_susceptibility_to | 2.14397907 |
| 20 | MP0002723_abnormal_immune_serum | 2.05474531 |
| 21 | MP0000569_abnormal_digit_pigmentation | 2.05328640 |
| 22 | MP0003303_peritoneal_inflammation | 2.05007663 |
| 23 | MP0002166_altered_tumor_susceptibility | 2.04542473 |
| 24 | MP0005025_abnormal_response_to | 2.04291640 |
| 25 | * MP0002420_abnormal_adaptive_immunity | 2.03631043 |
| 26 | * MP0001819_abnormal_immune_cell | 2.01402633 |
| 27 | MP0003724_increased_susceptibility_to | 1.99375898 |
| 28 | MP0000465_gastrointestinal_hemorrhage | 1.99114515 |
| 29 | MP0005174_abnormal_tail_pigmentation | 1.94179318 |
| 30 | * MP0002398_abnormal_bone_marrow | 1.92383152 |
| 31 | * MP0002405_respiratory_system_inflammati | 1.89686000 |
| 32 | * MP0003763_abnormal_thymus_physiology | 1.89405444 |
| 33 | MP0001853_heart_inflammation | 1.88965103 |
| 34 | MP0010155_abnormal_intestine_physiology | 1.78252169 |
| 35 | MP0002877_abnormal_melanocyte_morpholog | 1.71900814 |
| 36 | MP0010352_gastrointestinal_tract_polyps | 1.70421842 |
| 37 | MP0002006_tumorigenesis | 1.69834518 |
| 38 | * MP0000716_abnormal_immune_system | 1.69028836 |
| 39 | * MP0000689_abnormal_spleen_morphology | 1.62854663 |
| 40 | MP0004947_skin_inflammation | 1.62767927 |
| 41 | MP0003705_abnormal_hypodermis_morpholog | 1.62366918 |
| 42 | * MP0002722_abnormal_immune_system | 1.60371916 |
| 43 | MP0000490_abnormal_crypts_of | 1.57521986 |
| 44 | MP0001533_abnormal_skeleton_physiology | 1.53473006 |
| 45 | MP0006082_CNS_inflammation | 1.53127151 |
| 46 | MP0001873_stomach_inflammation | 1.51812698 |
| 47 | MP0004510_myositis | 1.49388267 |
| 48 | * MP0002429_abnormal_blood_cell | 1.46338327 |
| 49 | MP0003566_abnormal_cell_adhesion | 1.46292105 |
| 50 | MP0005503_abnormal_tendon_morphology | 1.45411388 |
| 51 | * MP0000703_abnormal_thymus_morphology | 1.42740246 |
| 52 | MP0002933_joint_inflammation | 1.40913571 |
| 53 | MP0006054_spinal_hemorrhage | 1.39460076 |
| 54 | MP0009333_abnormal_splenocyte_physiolog | 1.38996579 |
| 55 | MP0001845_abnormal_inflammatory_respons | 1.37210940 |
| 56 | MP0005023_abnormal_wound_healing | 1.36487233 |
| 57 | MP0008007_abnormal_cellular_replicative | 1.33743110 |
| 58 | MP0003828_pulmonary_edema | 1.32079641 |
| 59 | MP0003448_altered_tumor_morphology | 1.31969195 |
| 60 | MP0008438_abnormal_cutaneous_collagen | 1.27449807 |
| 61 | MP0003656_abnormal_erythrocyte_physiolo | 1.27326274 |
| 62 | * MP0000858_altered_metastatic_potential | 1.26479842 |
| 63 | MP0001851_eye_inflammation | 1.22226665 |
| 64 | MP0002998_abnormal_bone_remodeling | 1.20655141 |
| 65 | MP0005409_darkened_coat_color | 1.20356464 |
| 66 | MP0001542_abnormal_bone_strength | 1.18567648 |
| 67 | MP0009840_abnormal_foam_cell | 1.17564183 |
| 68 | MP0005076_abnormal_cell_differentiation | 1.16455864 |
| 69 | MP0004883_abnormal_blood_vessel | 1.14251311 |
| 70 | MP0002060_abnormal_skin_morphology | 1.13564880 |
| 71 | MP0005058_abnormal_lysosome_morphology | 1.12435788 |
| 72 | MP0000015_abnormal_ear_pigmentation | 1.12032275 |
| 73 | MP0000343_altered_response_to | 1.11950559 |
| 74 | MP0003866_abnormal_defecation | 1.11670217 |
| 75 | MP0010307_abnormal_tumor_latency | 1.11306336 |
| 76 | MP0003950_abnormal_plasma_membrane | 1.10701943 |
| 77 | MP0002132_abnormal_respiratory_system | 1.09649648 |
| 78 | MP0003045_fibrosis | 1.08730876 |
| 79 | MP0002095_abnormal_skin_pigmentation | 1.05104194 |
| 80 | MP0001958_emphysema | 1.01106770 |
| 81 | MP0008004_abnormal_stomach_pH | 0.99919518 |
| 82 | MP0005075_abnormal_melanosome_morpholog | 0.99526689 |
| 83 | MP0003172_abnormal_lysosome_physiology | 0.98894143 |
| 84 | * MP0005390_skeleton_phenotype | 0.98704990 |
| 85 | MP0003693_abnormal_embryo_hatching | 0.95541949 |
| 86 | * MP0002019_abnormal_tumor_incidence | 0.94614308 |
| 87 | MP0000733_abnormal_muscle_development | 0.93883013 |
| 88 | MP0010094_abnormal_chromosome_stability | 0.93222556 |
| 89 | MP0002254_reproductive_system_inflammat | 0.92568784 |
| 90 | MP0008469_abnormal_protein_level | 0.91615508 |
| 91 | * MP0003279_aneurysm | 0.91274357 |
| 92 | MP0005166_decreased_susceptibility_to | 0.91221021 |
| 93 | MP0008057_abnormal_DNA_replication | 0.90660397 |
| 94 | MP0003075_altered_response_to | 0.89739547 |
| 95 | MP0003795_abnormal_bone_structure | 0.88290445 |
| 96 | MP0003191_abnormal_cellular_cholesterol | 0.86678150 |
| 97 | MP0009764_decreased_sensitivity_to | 0.86144543 |
| 98 | MP0000767_abnormal_smooth_muscle | 0.85613770 |
| 99 | MP0004381_abnormal_hair_follicle | 0.85444424 |
| 100 | MP0003943_abnormal_hepatobiliary_system | 0.85102860 |
| 101 | MP0003077_abnormal_cell_cycle | 0.84184930 |
| 102 | MP0001243_abnormal_dermal_layer | 0.81218614 |
| 103 | MP0001216_abnormal_epidermal_layer | 0.80293228 |
| 104 | MP0005165_increased_susceptibility_to | 0.79798481 |
| 105 | MP0009384_cardiac_valve_regurgitation | 0.78347388 |
| 106 | MP0009931_abnormal_skin_appearance | 0.77395387 |
| 107 | MP0001849_ear_inflammation | 0.77170850 |
| 108 | MP0003091_abnormal_cell_migration | 0.76529176 |
| 109 | MP0003453_abnormal_keratinocyte_physiol | 0.75153593 |
| 110 | MP0005275_abnormal_skin_tensile | 0.75054994 |
| 111 | MP0002009_preneoplasia | 0.74709872 |
| 112 | MP0000371_diluted_coat_color | 0.73788406 |
| 113 | MP0009763_increased_sensitivity_to | 0.73310869 |
| 114 | MP0004185_abnormal_adipocyte_glucose | 0.72907280 |
| 115 | MP0010368_abnormal_lymphatic_system | 0.69623724 |
| 116 | MP0005310_abnormal_salivary_gland | 0.68705404 |
| 117 | MP0003183_abnormal_peptide_metabolism | 0.68297768 |
| 118 | MP0005164_abnormal_response_to | 0.67991167 |
| 119 | MP0000249_abnormal_blood_vessel | 0.66576968 |
| 120 | MP0003111_abnormal_nucleus_morphology | 0.65870090 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Recurrent abscess formation (HP:0002722) | 4.38302527 |
| 2 | Eczematoid dermatitis (HP:0000976) | 4.15170724 |
| 3 | Recurrent bacterial skin infections (HP:0005406) | 4.11770970 |
| 4 | Myositis (HP:0100614) | 3.77956820 |
| 5 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.52202735 |
| 6 | Recurrent fungal infections (HP:0002841) | 3.39118905 |
| 7 | Cellulitis (HP:0100658) | 3.34217320 |
| 8 | Recurrent viral infections (HP:0004429) | 3.10810505 |
| 9 | Petechiae (HP:0000967) | 3.08907259 |
| 10 | IgM deficiency (HP:0002850) | 3.02050500 |
| 11 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.98829910 |
| 12 | Osteolytic defects of the hand bones (HP:0009699) | 2.98829910 |
| 13 | Orchitis (HP:0100796) | 2.98288433 |
| 14 | Syringomyelia (HP:0003396) | 2.92380273 |
| 15 | Spinal cord lesions (HP:0100561) | 2.92380273 |
| 16 | Acute lymphatic leukemia (HP:0006721) | 2.84399889 |
| 17 | Abnormality of the fingertips (HP:0001211) | 2.84281388 |
| 18 | Prostate neoplasm (HP:0100787) | 2.83546118 |
| 19 | Thrombocytosis (HP:0001894) | 2.76087197 |
| 20 | Aortic dissection (HP:0002647) | 2.73824427 |
| 21 | Periodontitis (HP:0000704) | 2.72641381 |
| 22 | Mediastinal lymphadenopathy (HP:0100721) | 2.72012533 |
| 23 | Panhypogammaglobulinemia (HP:0003139) | 2.71731253 |
| 24 | Optic neuritis (HP:0100653) | 2.68156959 |
| 25 | Retrobulbar optic neuritis (HP:0100654) | 2.68156959 |
| 26 | * Prolonged bleeding time (HP:0003010) | 2.68086214 |
| 27 | Recurrent skin infections (HP:0001581) | 2.67093362 |
| 28 | Chronic otitis media (HP:0000389) | 2.62382279 |
| 29 | Interstitial pulmonary disease (HP:0006530) | 2.59425593 |
| 30 | Meningitis (HP:0001287) | 2.58476582 |
| 31 | Dysostosis multiplex (HP:0000943) | 2.55819397 |
| 32 | Pustule (HP:0200039) | 2.54718891 |
| 33 | Autoimmune hemolytic anemia (HP:0001890) | 2.53577678 |
| 34 | Osteomyelitis (HP:0002754) | 2.51787336 |
| 35 | Abnormality of the prostate (HP:0008775) | 2.50794331 |
| 36 | Peritonitis (HP:0002586) | 2.45336385 |
| 37 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.42329698 |
| 38 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.42329698 |
| 39 | Abnormality of glycolipid metabolism (HP:0010969) | 2.42329698 |
| 40 | Leukocytosis (HP:0001974) | 2.41896169 |
| 41 | Eosinophilia (HP:0001880) | 2.40966632 |
| 42 | Dilatation of the ascending aorta (HP:0005111) | 2.39734968 |
| 43 | Spondylolisthesis (HP:0003302) | 2.39664696 |
| 44 | Thyroiditis (HP:0100646) | 2.38329807 |
| 45 | Recurrent cutaneous fungal infections (HP:0011370) | 2.36456973 |
| 46 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.36456973 |
| 47 | Abnormality of macrophages (HP:0004311) | 2.36396481 |
| 48 | Cervical subluxation (HP:0003308) | 2.35719062 |
| 49 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.34401501 |
| 50 | Gingival bleeding (HP:0000225) | 2.30742886 |
| 51 | Chronic obstructive pulmonary disease (HP:0006510) | 2.30464489 |
| 52 | Obstructive lung disease (HP:0006536) | 2.30464489 |
| 53 | Vasculitis (HP:0002633) | 2.30306195 |
| 54 | Agammaglobulinemia (HP:0004432) | 2.30029424 |
| 55 | Inflammation of the large intestine (HP:0002037) | 2.29508942 |
| 56 | Abnormality of B cell number (HP:0010975) | 2.27076096 |
| 57 | B lymphocytopenia (HP:0010976) | 2.27076096 |
| 58 | Autoimmune thrombocytopenia (HP:0001973) | 2.26964450 |
| 59 | Absent frontal sinuses (HP:0002688) | 2.26329424 |
| 60 | Vascular tortuosity (HP:0004948) | 2.22934975 |
| 61 | Gastrointestinal inflammation (HP:0004386) | 2.20474753 |
| 62 | Gingivitis (HP:0000230) | 2.20327036 |
| 63 | Increased density of long bones (HP:0006392) | 2.20120477 |
| 64 | Arterial thrombosis (HP:0004420) | 2.17961385 |
| 65 | Abnormal platelet volume (HP:0011876) | 2.15176538 |
| 66 | Broad face (HP:0000283) | 2.14783916 |
| 67 | * Acute myeloid leukemia (HP:0004808) | 2.14611010 |
| 68 | * Epistaxis (HP:0000421) | 2.14120169 |
| 69 | Fragile skin (HP:0001030) | 2.13012590 |
| 70 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.12996840 |
| 71 | Mucopolysacchariduria (HP:0008155) | 2.12996840 |
| 72 | T lymphocytopenia (HP:0005403) | 2.12938322 |
| 73 | Arterial tortuosity (HP:0005116) | 2.12818048 |
| 74 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.12524181 |
| 75 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.12524181 |
| 76 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.12524181 |
| 77 | Spontaneous hematomas (HP:0007420) | 2.10895968 |
| 78 | Urethral obstruction (HP:0000796) | 2.09105997 |
| 79 | Delayed closure of the anterior fontanelle (HP:0001476) | 2.08694125 |
| 80 | Hematochezia (HP:0002573) | 2.08278089 |
| 81 | Granulocytopenia (HP:0001913) | 2.05650656 |
| 82 | Aneurysm (HP:0002617) | 2.05026723 |
| 83 | Abnormality of eosinophils (HP:0001879) | 2.03554979 |
| 84 | Abnormality of T cell number (HP:0011839) | 2.02978496 |
| 85 | Recurrent bronchitis (HP:0002837) | 2.02604788 |
| 86 | Aortic regurgitation (HP:0001659) | 2.02386682 |
| 87 | Lip pit (HP:0100267) | 2.02175388 |
| 88 | Cone-shaped epiphyses of the phalanges of the hand (HP:0010230) | 2.02057708 |
| 89 | Abnormality of T cells (HP:0002843) | 2.02007788 |
| 90 | Increased IgE level (HP:0003212) | 2.01417712 |
| 91 | Follicular hyperkeratosis (HP:0007502) | 2.00793293 |
| 92 | Thick nail (HP:0001805) | 2.00581760 |
| 93 | * Impaired platelet aggregation (HP:0003540) | 1.96103935 |
| 94 | * Abnormal platelet function (HP:0011869) | 1.96103935 |
| 95 | Distal lower limb amyotrophy (HP:0008944) | 1.95526035 |
| 96 | Cerebral aneurysm (HP:0004944) | 1.95443518 |
| 97 | Submucous cleft hard palate (HP:0000176) | 1.95257889 |
| 98 | Distal lower limb muscle weakness (HP:0009053) | 1.93815755 |
| 99 | Aortic aneurysm (HP:0004942) | 1.93496618 |
| 100 | Colitis (HP:0002583) | 1.91706006 |
| 101 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.91192851 |
| 102 | Vacuolated lymphocytes (HP:0001922) | 1.90842240 |
| 103 | Polygenic inheritance (HP:0010982) | 1.90760471 |
| 104 | Entropion (HP:0000621) | 1.89772339 |
| 105 | Thoracic kyphosis (HP:0002942) | 1.89109939 |
| 106 | Blue sclerae (HP:0000592) | 1.88978479 |
| 107 | Abnormality of T cell physiology (HP:0011840) | 1.88133484 |
| 108 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.87487228 |
| 109 | Wormian bones (HP:0002645) | 1.86977749 |
| 110 | Genu recurvatum (HP:0002816) | 1.86299380 |
| 111 | Pulmonary infiltrates (HP:0002113) | 1.85807347 |
| 112 | Aplasia/Hypoplasia involving the sinuses (HP:0009120) | 1.84747186 |
| 113 | Reticulocytopenia (HP:0001896) | 1.84159120 |
| 114 | Skin ulcer (HP:0200042) | 1.82771723 |
| 115 | Abnormality of the thoracic spine (HP:0100711) | 1.81956021 |
| 116 | Keratoconjunctivitis sicca (HP:0001097) | 1.81613730 |
| 117 | Increased cerebral lipofuscin (HP:0011813) | 1.80223646 |
| 118 | Recurrent pneumonia (HP:0006532) | 1.79539551 |
| 119 | Stomatitis (HP:0010280) | 1.79396836 |
| 120 | Atrophic scars (HP:0001075) | 1.78256512 |
| 121 | * Bruising susceptibility (HP:0000978) | 1.77174748 |
| 122 | Joint stiffness (HP:0001387) | 1.76442761 |
| 123 | Increased mean platelet volume (HP:0011877) | 1.76385022 |
| 124 | Vertebral compression fractures (HP:0002953) | 1.75458104 |
| 125 | Mitral valve prolapse (HP:0001634) | 1.73576694 |
| 126 | Abnormality of the nasal mucosa (HP:0000433) | 1.73467326 |
| 127 | Abnormality of the columella (HP:0009929) | 1.72535957 |
| 128 | Sparse lateral eyebrow (HP:0005338) | 1.72394922 |
| 129 | Premature rupture of membranes (HP:0001788) | 1.72387365 |
| 130 | Recurrent lower respiratory tract infections (HP:0002783) | 1.72143409 |
| 131 | Hemoptysis (HP:0002105) | 1.70699242 |
| 132 | Sepsis (HP:0100806) | 1.70163144 |
| 133 | Obstructive sleep apnea (HP:0002870) | 1.69170916 |
| 134 | Chronic diarrhea (HP:0002028) | 1.68946820 |
| 135 | Abnormality of the peritoneum (HP:0002585) | 1.68343261 |
| 136 | Thin bony cortex (HP:0002753) | 1.67962633 |
| 137 | Chest pain (HP:0100749) | 1.67840493 |
| 138 | Glomerulopathy (HP:0100820) | 1.67649150 |
| 139 | Aplasia/Hypoplasia of the frontal sinuses (HP:0009119) | 1.67599838 |
| 140 | Increased variability in muscle fiber diameter (HP:0003557) | 1.67581446 |
| 141 | Protrusio acetabuli (HP:0003179) | 1.65427507 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K1 | 3.67841105 |
| 2 | TXK | 2.73154827 |
| 3 | KIT | 2.69806257 |
| 4 | PRPF4B | 2.32428677 |
| 5 | STK10 | 2.09331514 |
| 6 | MAP3K14 | 2.08275920 |
| 7 | JAK3 | 2.06547058 |
| 8 | IRAK4 | 2.05162758 |
| 9 | TGFBR2 | 2.03741167 |
| 10 | TEC | 2.02119795 |
| 11 | PIM2 | 2.01490331 |
| 12 | ZAP70 | 1.98685118 |
| 13 | BTK | 1.95245654 |
| 14 | TYK2 | 1.90802590 |
| 15 | NME2 | 1.82785785 |
| 16 | RPS6KA4 | 1.82713142 |
| 17 | EEF2K | 1.82680312 |
| 18 | MAP2K3 | 1.79970718 |
| 19 | TBK1 | 1.75519418 |
| 20 | IKBKB | 1.68280877 |
| 21 | BLK | 1.64222114 |
| 22 | MAP3K13 | 1.60889725 |
| 23 | EPHB1 | 1.60852990 |
| 24 | IKBKE | 1.55876692 |
| 25 | IRAK3 | 1.50513108 |
| 26 | NEK9 | 1.49441063 |
| 27 | EPHA3 | 1.48393678 |
| 28 | CDC42BPA | 1.47545553 |
| 29 | ERN1 | 1.46571118 |
| 30 | MAP3K10 | 1.45643590 |
| 31 | MAP3K3 | 1.42095582 |
| 32 | CSF1R | 1.38104888 |
| 33 | TAOK3 | 1.37974674 |
| 34 | PDGFRA | 1.37347696 |
| 35 | PIM1 | 1.36210637 |
| 36 | MAP3K6 | 1.35544340 |
| 37 | CLK1 | 1.33877941 |
| 38 | AKT3 | 1.33018973 |
| 39 | SMG1 | 1.32909563 |
| 40 | SYK | 1.31787126 |
| 41 | CDK12 | 1.31191763 |
| 42 | HCK | 1.30716637 |
| 43 | TRPM7 | 1.29650198 |
| 44 | CHUK | 1.29366143 |
| 45 | SIK1 | 1.28393173 |
| 46 | JAK1 | 1.27951247 |
| 47 | RIPK4 | 1.26959464 |
| 48 | NLK | 1.22802765 |
| 49 | ITK | 1.21257699 |
| 50 | RPS6KB2 | 1.20782115 |
| 51 | FGFR3 | 1.20314786 |
| 52 | LRRK2 | 1.19722651 |
| 53 | LCK | 1.12938413 |
| 54 | RIPK1 | 1.04476185 |
| 55 | BMPR2 | 1.02900404 |
| 56 | MAP3K7 | 1.01826250 |
| 57 | SIK3 | 1.00671786 |
| 58 | DDR2 | 0.98711418 |
| 59 | MATK | 0.98289986 |
| 60 | PRKD2 | 0.96541047 |
| 61 | MAP3K1 | 0.96201153 |
| 62 | FLT3 | 0.96123070 |
| 63 | IRAK1 | 0.95291932 |
| 64 | MST4 | 0.94933233 |
| 65 | ZAK | 0.93637212 |
| 66 | FGFR4 | 0.92475485 |
| 67 | LYN | 0.92185006 |
| 68 | CDK8 | 0.91502516 |
| 69 | CSK | 0.91150292 |
| 70 | MAPK15 | 0.89932597 |
| 71 | MARK2 | 0.89701308 |
| 72 | STK4 | 0.88805480 |
| 73 | TGFBR1 | 0.87401224 |
| 74 | ICK | 0.87271613 |
| 75 | PAK4 | 0.87202190 |
| 76 | MELK | 0.87068374 |
| 77 | MKNK1 | 0.83761060 |
| 78 | MAP3K2 | 0.80371368 |
| 79 | PAK2 | 0.78981849 |
| 80 | GRK7 | 0.78975204 |
| 81 | MAPKAPK5 | 0.78899932 |
| 82 | MAPK11 | 0.78247645 |
| 83 | CDK9 | 0.78205973 |
| 84 | FES | 0.77985590 |
| 85 | MAPKAPK2 | 0.75608587 |
| 86 | TAOK2 | 0.75307856 |
| 87 | RPS6KA6 | 0.74854826 |
| 88 | * HIPK2 | 0.74824488 |
| 89 | MTOR | 0.74416674 |
| 90 | STK38 | 0.72103244 |
| 91 | STK3 | 0.67274419 |
| 92 | MYLK | 0.63991879 |
| 93 | CDC7 | 0.63826670 |
| 94 | PIK3CG | 0.63538714 |
| 95 | RPS6KL1 | 0.62672658 |
| 96 | RPS6KC1 | 0.62672658 |
| 97 | MARK3 | 0.62312143 |
| 98 | JAK2 | 0.60303996 |
| 99 | EPHA2 | 0.59842626 |
| 100 | CAMK1D | 0.59541101 |
| 101 | MKNK2 | 0.59376019 |
| 102 | MAPK4 | 0.58928996 |
| 103 | WNK1 | 0.58197663 |
| 104 | ATR | 0.57294878 |
| 105 | PKN2 | 0.56009043 |
| 106 | NUAK1 | 0.55916537 |
| 107 | SIK2 | 0.54775949 |
| 108 | RPS6KA5 | 0.54601149 |
| 109 | MAPKAPK3 | 0.54538329 |
| 110 | TTN | 0.54377317 |
| 111 | TRIB3 | 0.54367321 |
| 112 | MST1R | 0.53389108 |
| 113 | TAOK1 | 0.52898955 |
| 114 | MAP3K11 | 0.51244800 |
| 115 | BRD4 | 0.51100192 |
| 116 | PDGFRB | 0.51062142 |
| 117 | PTK6 | 0.50199555 |
| 118 | FRK | 0.49935441 |
| 119 | CDK4 | 0.49549483 |
| 120 | VRK1 | 0.48138186 |
| 121 | CDK7 | 0.47957622 |
| 122 | MAP3K8 | 0.47734846 |
| 123 | MOS | 0.47328705 |
| 124 | ADRBK2 | 0.46743232 |
| 125 | STK24 | 0.44183857 |
| 126 | ABL1 | 0.43030945 |
| 127 | TNK2 | 0.42773908 |
| 128 | GRK6 | 0.41231385 |
| 129 | ERBB3 | 0.40319861 |
| 130 | MAP2K2 | 0.40166402 |
| 131 | MAPK7 | 0.39551313 |
| 132 | RPS6KA2 | 0.38174199 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Leishmaniasis_Homo sapiens_hsa05140 | 2.54775438 |
| 2 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.17935680 |
| 3 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.15390737 |
| 4 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.12990714 |
| 5 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.07573264 |
| 6 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 2.04831044 |
| 7 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.03680252 |
| 8 | Measles_Homo sapiens_hsa05162 | 1.95854130 |
| 9 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.80447723 |
| 10 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.71237500 |
| 11 | Malaria_Homo sapiens_hsa05144 | 1.68006408 |
| 12 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.64901012 |
| 13 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.61958549 |
| 14 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.51841655 |
| 15 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.51439574 |
| 16 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.49661098 |
| 17 | Pertussis_Homo sapiens_hsa05133 | 1.49418443 |
| 18 | Legionellosis_Homo sapiens_hsa05134 | 1.44662100 |
| 19 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.44013580 |
| 20 | Hepatitis B_Homo sapiens_hsa05161 | 1.43952265 |
| 21 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.43329736 |
| 22 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.42008193 |
| 23 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.39635486 |
| 24 | DNA replication_Homo sapiens_hsa03030 | 1.39473775 |
| 25 | Apoptosis_Homo sapiens_hsa04210 | 1.38788955 |
| 26 | * Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.38407388 |
| 27 | Tuberculosis_Homo sapiens_hsa05152 | 1.37763571 |
| 28 | Influenza A_Homo sapiens_hsa05164 | 1.37195852 |
| 29 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.36030399 |
| 30 | * Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.33478004 |
| 31 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.33131735 |
| 32 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.31153182 |
| 33 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.31003496 |
| 34 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.30041843 |
| 35 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.29192670 |
| 36 | * Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.28219619 |
| 37 | Asthma_Homo sapiens_hsa05310 | 1.26612595 |
| 38 | Platelet activation_Homo sapiens_hsa04611 | 1.26220041 |
| 39 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.25331971 |
| 40 | Shigellosis_Homo sapiens_hsa05131 | 1.24970540 |
| 41 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.20783140 |
| 42 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.20148305 |
| 43 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.19972915 |
| 44 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.18905844 |
| 45 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.17734308 |
| 46 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.15046750 |
| 47 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.14626594 |
| 48 | Salmonella infection_Homo sapiens_hsa05132 | 1.12027472 |
| 49 | Ribosome_Homo sapiens_hsa03010 | 1.10980984 |
| 50 | Allograft rejection_Homo sapiens_hsa05330 | 1.10835231 |
| 51 | Bladder cancer_Homo sapiens_hsa05219 | 1.08575015 |
| 52 | Base excision repair_Homo sapiens_hsa03410 | 1.04607267 |
| 53 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.03707751 |
| 54 | Viral myocarditis_Homo sapiens_hsa05416 | 1.02224148 |
| 55 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.00648630 |
| 56 | HTLV-I infection_Homo sapiens_hsa05166 | 1.00226809 |
| 57 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.98921392 |
| 58 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.97818075 |
| 59 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.97228636 |
| 60 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.96319041 |
| 61 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.91498804 |
| 62 | Other glycan degradation_Homo sapiens_hsa00511 | 0.90343660 |
| 63 | Homologous recombination_Homo sapiens_hsa03440 | 0.90251774 |
| 64 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.88002591 |
| 65 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.86808154 |
| 66 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.86359993 |
| 67 | Cell cycle_Homo sapiens_hsa04110 | 0.82691220 |
| 68 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.81881912 |
| 69 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.81156929 |
| 70 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.79687451 |
| 71 | Hepatitis C_Homo sapiens_hsa05160 | 0.79404332 |
| 72 | Lysosome_Homo sapiens_hsa04142 | 0.76698165 |
| 73 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.76559016 |
| 74 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.74980384 |
| 75 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.74325390 |
| 76 | Amoebiasis_Homo sapiens_hsa05146 | 0.74225211 |
| 77 | Mismatch repair_Homo sapiens_hsa03430 | 0.73189407 |
| 78 | Colorectal cancer_Homo sapiens_hsa05210 | 0.73186021 |
| 79 | Insulin resistance_Homo sapiens_hsa04931 | 0.71585075 |
| 80 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.70997423 |
| 81 | Phagosome_Homo sapiens_hsa04145 | 0.70745458 |
| 82 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.69884586 |
| 83 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.69702905 |
| 84 | Glioma_Homo sapiens_hsa05214 | 0.69692722 |
| 85 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.69029624 |
| 86 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.68516187 |
| 87 | Prostate cancer_Homo sapiens_hsa05215 | 0.68367893 |
| 88 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.67342038 |
| 89 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.66885293 |
| 90 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.66500314 |
| 91 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.65579743 |
| 92 | Focal adhesion_Homo sapiens_hsa04510 | 0.65546699 |
| 93 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.65541837 |
| 94 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.63509239 |
| 95 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.63276733 |
| 96 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.62248835 |
| 97 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.60056494 |
| 98 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.60055446 |
| 99 | Thyroid cancer_Homo sapiens_hsa05216 | 0.59509625 |
| 100 | Endometrial cancer_Homo sapiens_hsa05213 | 0.57573403 |
| 101 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.56161851 |
| 102 | Adherens junction_Homo sapiens_hsa04520 | 0.55133834 |
| 103 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.55030122 |
| 104 | * Pathways in cancer_Homo sapiens_hsa05200 | 0.54739996 |
| 105 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.54131859 |
| 106 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.53779161 |
| 107 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.53483916 |
| 108 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.53468598 |
| 109 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.53048006 |
| 110 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.52600826 |
| 111 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.50688436 |
| 112 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.50116400 |
| 113 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.49952259 |
| 114 | Endocytosis_Homo sapiens_hsa04144 | 0.47645478 |
| 115 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.47457902 |
| 116 | RNA degradation_Homo sapiens_hsa03018 | 0.45824495 |
| 117 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.43736880 |
| 118 | Spliceosome_Homo sapiens_hsa03040 | 0.43665702 |
| 119 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.38511174 |
| 120 | Melanoma_Homo sapiens_hsa05218 | 0.38094010 |
| 121 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.36713393 |

